The past 5–10 years have seen rapid advances in digital sensors and imaging-based technologies for the diagnosis of neurological conditions. However, the majority of these technologies are in the early stages of development — now is the time to consider how we validate these tools and safely integrate them into clinical practice.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study
Journal of Neurology Open Access 30 August 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cohen, A. B. & Nahed, B. V. The digital neurologic examination. Digit. Biomark. 5, 114–126 (2021).
Woelfle, T. et al. Reliability and acceptance of a smartphone-based remote monitoring app (dreaMS) for people with MS–results of a feasibility study. Am. Acad. Neurol. https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-002838.html (2022).
Montalban, X. et al. A smartphone sensor-based digital outcome assessment of multiple sclerosis. Mult. Scler. 28, 654–664 (2022).
Zhan, A. et al. Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. 75, 876–880 (2018).
Howett, D. et al. Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation. Brain 142, 1751–1766 (2019).
Pemberton, H. G. et al. Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review. Neuroradiology 63, 1773–1789 (2021).
Danelakis, A., Theoharis, T. & Verganelakis, D. A. Survey of automated multiple sclerosis lesion segmentation techniques on magnetic resonance imaging. Comput. Med. Imaging Graph. 70, 83–100 (2018).
Bivard, A., Churilov, L. & Parsons, M. Artificial intelligence for decision support in acute stroke — current roles and potential. Nat. Rev. Neurol. 16, 575–585 (2020).
Goldsack, J. C. et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for biometric monitoring technologies (BioMeTs). NPJ Digit. Med. 3, 55 (2020).
Walton, M. K. et al. Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials. Contemp. Clin. Trials 91, 105962 (2020).
Acknowledgements
We thank M. Bach Cuadra for the layout of Fig. 1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
Digital Medicine society (DiMe) Library of Digital Endpoints: https://www.dimesociety.org/communication-education/library-of-digital-endpoints/
Rights and permissions
About this article
Cite this article
Granziera, C., Woelfle, T. & Kappos, L. Development and implementation of new diagnostic technologies in neurology. Nat Rev Neurol 18, 445–446 (2022). https://doi.org/10.1038/s41582-022-00692-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-022-00692-z